UK markets open in 2 hours 32 minutes

GH Dec 2022 210.000 call

OPR - OPR Delayed price. Currency in USD
Add to watchlist
3.50000.0000 (0.00%)
As of 04:22PM EST. Market open.
Full screen
Previous close3.5000
Open3.5000
Bid4.3000
Ask8.9000
Strike210.00
Expiry date2022-12-16
Day's range3.5000 - 3.5000
Contract rangeN/A
Volume1
Open interest1
  • Business Wire

    Study Shows Guardant360® Liquid Biopsy Test Helps Guide Treatment for Patients with HER2-Driven Metastatic Colorectal Cancer

    REDWOOD CITY, Calif., November 11, 2021--Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, announced today that a study published in Nature Medicine reinforces the benefits of using the Guardant360® liquid biopsy test to help guide treatment decisions for patients with HER2-driven metastatic colorectal cancer (mCRC). Led by the National Cancer Center Hospital East (NCCHE) in Japan, the study demonstrates that the Guardant360 test can select patients for HER2-directed ther

  • Business Wire

    Guardant Health to Participate in the 2021 Stifel Healthcare Conference

    REDWOOD CITY, Calif., November 08, 2021--Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced the company will be participating virtually in the upcoming 2021 Stifel Healthcare Conference.

  • Motley Fool

    Guardant Health Inc (GH) Q3 2021 Earnings Call Transcript

    Earlier today Guardant Health released financial results for the quarter ended September 30, 2021. Joining me today from Guardant are Helmy Eltoukhy, Co-CEO, AmirAli Talasaz, Co-CEO and Mike Bell, Chief Financial Officer. Additional information regarding these risks and uncertainties, appears in the section entitled Forward-Looking Statements in the press release Guardant issued today.